CELL SEARCH SYSTEM -CELL BANK- (RIKEN BRC) [RCB0555 : GCIY]

4757 Nozue M, Nishida M, Todoroki T, Fukao K, Tanaka M. Selection of three out of 24 anti-cancer agents in poorly-differentiated gastric cancer cell lines, evaluated by the AUC/delta IC50 ratio. Anticancer Drugs 1995 6(2):291-302 PubMed ID: 7795277 DOI: 10.1097/00001813-199504000-00014

4758 Nozue M, Todoroki T, Fukao K. 5-fu dose-dependency in mtx/s-fu sequential therapy assessed by in-vitro assay using gastric-cancer cell-lines. Oncol Rep 1995 2(5):737-40 PubMed ID: 21597807 DOI: 10.3892/or.2.5.737

1324 Nozue M, Nishida M, Todoroki T, Iwasaki Y [Establishment and characterization of a human scirrhus type gastric cancer cell line, GCIY, producing CA19-9] Hum Cell 1991 4:71-5 PubMed ID: 1653599

Top

User's Publication

20619 Shirakihara T, Yamaguchi H, Kondo T, Yashiro M, Sakai R. Transferrin receptor 1 promotes the fibroblast growth factor receptor-mediated oncogenic potential of diffused-type gastric cancer. Oncogene 2022 PubMed ID: 35338344 DOI: 10.1038/s41388-022-02270-5

20642 Kasai S, Kuwayama N, Motoo Y, Kawashima A, Matsumoto K, Yano S, Matsushima K, Yasumoto K. Dual blockade of MET and VEGFR2 signaling pathways as a potential therapeutic maneuver for peritoneal carcinomatosis in scirrhous gastric cancer. Biochem Biophys Res Commun 2022 600:80-86 PubMed ID: 35196631 DOI: 10.1016/j.bbrc.2022.02.045

20664 Han Y, Dong Q, Liu T, Chen X, Yu C, Zhang Y. The novel mechanism of Med12-mediated drug resistance in a TGFBR2-independent manner. Biochem Biophys Res Commun 2022 610:1-7 PubMed ID: 35461070 DOI: 10.1016/j.bbrc.2022.04.029

20907 Sera T, Sakuma T, Maruo K, Tsujio G, Yamamoto Y, Sugimoto A, Kushiyama S, Togano S, Kuroda K, Kasashima H, Ohira M, Maeda K. Candidate Oncogenes, ARHGAP4, NOS3, and OR51B5, for the Development of Scirrhous-type Gastric Cancer. Anticancer Res 2022 42(11):5195-5203 PubMed ID: 36288877 DOI: 10.21873/anticanres.16026

13281 Kajioka H, Kagawa S, Ito A, Yoshimoto M, Sakamoto S, Kikuchi S, Kuroda S, Yoshida R, Umeda Y, Noma K, Tazawa H, Fujiwara T. Targeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasis. Cancer Lett 2021 PubMed ID: 33065249 DOI: 10.1016/j.canlet.2020.10.015

13337 Kim S, Ahn JM, Bae WJ, Han JH, Lee D. Quantitation of ligand is critical for ligand-dependent MET signalling activation and determines MET-targeted therapeutic response in gastric cancer. Gastric Cancer 2021 24(3):577-588 PubMed ID: 33164142 DOI: 10.1007/s10120-020-01139-4

20028 Ito A, Kagawa S, Sakamoto S, Kuwada K, Kajioka H, Yoshimoto M, Kikuchi S, Kuroda S, Yoshida R, Tazawa H, Fujiwara T. Extracellular vesicles shed from gastric cancer mediate protumor macrophage differentiation. BMC Cancer 2021 21(1):102 PubMed ID: 33509150 DOI: 10.1186/s12885-021-07816-6

20191 Matsumi Y, Kagawa T, Yano S, Tazawa H, Shigeyasu K, Takeda S, Ohara T, Aono H, Hoffman RM, Fujiwara T, Kishimoto H. Hyperthermia generated by magnetic nanoparticles for effective treatment of disseminated peritoneal cancer in an orthotopic nude-mouse model. Cell Cycle 2021 1-12 PubMed ID: 34110969 DOI: 10.1080/15384101.2021.1919441

20415 Ikari N, Serizawa A, Tanji E, Yamamoto M, Furukawa T. Analysis of RHOA mutations and their significance in the proliferation and transcriptome of digestive tract cancer cells. Oncol Lett 2021 22(4):735 PubMed ID: 34466148 DOI: 10.3892/ol.2021.12996

16129 Nagamura Y, Miyazaki M, Nagano Y, Tomiyama A, Ohki R, Yanagihara K, Sakai R, Yamaguchi H. SHP2 as a Potential Therapeutic Target in Diffuse-Type Gastric Carcinoma Addicted to Receptor Tyrosine Kinase Signaling Cancers (Basel) 2021 13(17):4309 PubMed ID: 34503119 DOI: 10.3390/cancers13174309

13504 Baatar S, Bai T, Yokobori T, Gombodorj N, Nakazawa N, Ubukata Y, Kimura A, Kogure N, Sano A, Sohda M, Sakai M, Tumenjargal A, Ogata K, Kuwano H, Shirabe K, Saeki H. High RAD18 Expression is Associated with Disease Progression and Poor Prognosis in Patients with Gastric Cancer Ann Surg Oncol 2020 27(11):4360-4368 PubMed ID: 32356270 DOI: 10.1245/s10434-020-08518-2

16827 Ishikawa W, Kikuchi S, Ogawa T, Tabuchi M, Tazawa H, Kuroda S, Noma K, Nishizaki M, Kagawa S, Urata Y, Fujiwara T. Boosting Replication and Penetration of Oncolytic Adenovirus by Paclitaxel Eradicate Peritoneal Metastasis of Gastric Cancer Mol Ther Oncolytics 2020 18:262-271 PubMed ID: 32728614 DOI: 10.1016/j.omto.2020.06.021

11505 Kageyama-Yahara N, Yamamichi N, Takahashi Y, Takeuchi C, Matsumoto Y, Sakaguchi Y, Koike K. Tandem repeats of the 5' flanking region of human MUC5AC have a role as a novel enhancer in MUC5AC gene expression. Biochem Biophys Rep 2019 18:100632 PubMed ID: 30993217 DOI: 10.1016/j.bbrep.2019.100632

11511 Behan FM, Iorio F, Picco G, Gonçalves E, Beaver CM, Migliardi G, Santos R, Rao Y, Sassi F, Pinnelli M, Ansari R, Harper S, Jackson DA, McRae R, Pooley R, Wilkinson P, van der Meer D, Dow D, Buser-Doepner C, Bertotti A, Trusolino L, Stronach EA, Saez-Rodriguez J, Yusa K, Garnett MJ. Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. Nature 2019 PubMed ID: 30971826 DOI: 10.1038/s41586-019-1103-9

12415 Sakamoto S, Kagawa S, Kuwada K, Ito A, Kajioka H, Kakiuchi Y, Watanabe M, Kagawa T, Yoshida R, Kikuchi S, Kuroda S, Tazawa H, Fujiwara T. Intraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancer Oncoimmunology 2019 8(12):e1671760 PubMed ID: 31741772 DOI: 10.1080/2162402X.2019.1671760

14274 Chan EM, Shibue T, McFarland JM, Gaeta B, Ghandi M, Dumont N, Gonzalez A, McPartlan JS, Li T, Zhang Y, Bin Liu J, Lazaro JB, Gu P, Piett CG, Apffel A, Ali SO, Deasy R, Keskula P, Ng RWS, Roberts EA, Reznichenko E, Leung L, Alimova M, Schenone M, Islam M, Maruvka YE, Liu Y, Roper J, Raghavan S, Giannakis M, Tseng YY, Nagel ZD, D'Andrea A, Root DE, Boehm JS, Getz G, Chang S, Golub TR, Tsherniak A, Vazquez F, Bass AJ. WRN helicase is a synthetic lethal target in microsatellite unstable cancers Nature 2019 568(7753):551-556 PubMed ID: 30971823 DOI: 10.1038/s41586-019-1102-x

10662 Miyamoto S, Nagamura Y, Nakabo A, Okabe A, Yanagihara K, Fukami K, Sakai R, Yamaguchi H. Aberrant alternative splicing of RHOA is associated with loss of its expression and activity in diffuse-type gastric carcinoma cells. Biochem. Biophys. Res. Commun. 2018 495:1942-1947 PubMed ID: 29247652 DOI: 10.1016/j.bbrc.2017.12.067

4049 Taichi Yoshida, Takashi Maruyama, Masatomo Miura, Masahiro Inoue, Koji Fukuda, Kazuhiro Shimazu, Daiki Taguchi, Hiroaki Kanda, Masanobu Oshima, Yoshiharu Iwabuchi, Hiroyuki Shibata Dietary intake of pyrolyzed deketene curcumin inhibits gastric carcinogenesis Journal of Functional Foods 2018 50:192-200 DOI: 10.1016/j.jff.2018.09.033

4188 Suzuki M, Yokobori T, Gombodorj N, Yashiro M, Turtoi A, Handa T, Ogata K, Oyama T, Shirabe K, Kuwano H. High stromal transforming growth factor β-induced expression is a novel marker of progression and poor prognosis in gastric cancer. J Surg Oncol 2018 PubMed ID: 30260476 DOI: 10.1002/jso.25217

4380 Yoshioka T, Shien K, Namba K, Torigoe H, Sato H, Tomida S, Yamamoto H, Asano H, Soh J, Tsukuda K, Nagasaka T, Fujiwara T, Toyooka S. Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer. Cancer Sci. 2018 109(4):1166-1176 PubMed ID: 29465762 DOI: 10.1111/cas.13546

10277 Masuda T, Song W, Nakanishi H, Lei W, Noor AM, Arai F. Rare cell isolation and recovery on open-channel microfluidic chip. PLoS ONE 2017 12:e0174937 PubMed ID: 28426707 DOI: 10.1371/journal.pone.0174937

9594 Shibahara-Sone H, Gomi A, Iino T, Kano M, Nonaka C, Watanabe O, Miyazaki K, Ohkusa T. Living cells of probiotic Bifidobacterium bifidum YIT 10347 detected on gastric mucosa in humans. Benef Microbes 2016 7:319-26 PubMed ID: 26925600 DOI: 10.3920/BM2015.0138

9928 Diaz-Lagares A, Crujeiras AB, Lopez-Serra P, Soler M, Setien F, Goyal A, Sandoval J, Hashimoto Y, Martinez-Cardús A, Gomez A, Heyn H, Moutinho C, Espada J, Vidal A, Paúles M, Galán M, Sala N, Akiyama Y, Martínez-Iniesta M, Farré L, Villanueva A, Gross M, Diederichs S, Guil S, Esteller M. Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer. Proc. Natl. Acad. Sci. U.S.A. 2016 113:E7535-E7544 PubMed ID: 27821766 DOI: 10.1073/pnas.1608585113

3733 Nishikawaji T, Akiyama Y, Shimada S, Kojima K, Kawano T, Eishi Y, Yuasa Y, Tanaka S. Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer. Oncotarget 2016 7(41):67251-67265 PubMed ID: 27572307 DOI: 10.18632/oncotarget.11625

5811 Maejima R　et al Enhanced expression of semaphorin 3E is involved in the gastric cancer development. Int J Oncol 2016 49(3):887-94 PubMed ID: 27572291 DOI: 10.3892/ijo.2016.3593

5812 Hirashita Y et al Reduced phosphorylation of ribosomal protein S6 is associated with sensitivity to MEK inhibition in gastric cancer cells. Cancer Sci 2016 107(12):1919-1928 PubMed ID: 27699948 DOI: 10.1111/cas.13094

12639 Yamashita K, Kuno A, Matsuda A, Ikehata Y, Katada N, Hirabayashi J, Narimatsu H, Watanabe M. Lectin microarray technology identifies specific lectins related to lymph node metastasis of advanced gastric cancer Gastric Cancer 2016 19(2):531-54 PubMed ID: 25840959 DOI: 10.1007/s10120-015-0491-2

7357 Yamamoto S, Fei J, Okochi M, Shimizu K, Yusa A, Kondo N, Iwata H, Nakanishi H, Honda H. Efficient capturing of circulating tumor cells using a magnetic capture column and a size-selective filter. Bioprocess Biosyst Eng 2015 38:1693-704 PubMed ID: 25964183 DOI: 10.1007/s00449-015-1412-9

14977 Suenaga M, Yamada S, Fuchs BC, Fujii T, Kanda M, Tanaka C, Kobayashi D, Fujiwara M, Tanabe KK, Kodera Y. CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence J Surg Oncol 2015 112(6):622-8 PubMed ID: 26416034 DOI: 10.1002/jso.24056

15000 Sakamoto A, Akiyama Y, Shimada S, Zhu WG, Yuasa Y, Tanaka S. DNA Methylation in the Exon 1 Region and Complex Regulation of Twist1 Expression in Gastric Cancer Cells PLoS One 2015 10(12):e0145630 PubMed ID: 26695186 DOI: 10.1371/journal.pone.0145630

15183 Toda K, Nagasaka T, Umeda Y, Tanaka T, Kawai T, Fuji T, Taniguchi F, Yasui K, Kubota N, Takehara Y, Tazawa H, Kagawa S, Sun DS, Nishida N, Goel A, Fujiwara T. Genetic and epigenetic alterations of netrin-1 receptors in gastric cancer with chromosomal instability Clin Epigenetics 2015 7(1):73 PubMed ID: 26207151 DOI: 10.1186/s13148-015-0096-y

5825 Ito A, Ito Y, Matsushima S, Tsuchida D, Ogasawara M, Hasegawa J, Misawa K, Kondo E, Kaneda N, Nakanishi H. New whole-body multimodality imaging of gastric cancer peritoneal metastasis combining fluorescence imaging with ICG-labeled antibody and MRI in mice. Gastric Cancer 2014 17(3):497-507 PubMed ID: 24288123 DOI: 10.1007/s10120-013-0316-0

5302 Yamaguchi H, Takanashi M, Yoshida N, Ito Y, Kamata R, Fukami K, Yanagihara K, Sakai R. Saracatinib impairs the peritoneal dissemination of diffuse-type gastric carcinoma cells resistant to Met and fibroblast growth factor receptor inhibitors. Cancer Sci 2014 105(5):528-36 PubMed ID: 24612061 DOI: 10.1111/cas.12387

15817 Endo F, Nishizuka SS, Kume K, Ishida K, Katagiri H, Ishida K, Sato K, Iwaya T, Koeda K, Wakabayashi G. A compensatory role of NF-κB to p53 in response to 5-FU-based chemotherapy for gastric cancer cell lines PLoS One 2014 9(2):e90155 PubMed ID: 24587255 DOI: 10.1371/journal.pone.0090155

15987 Sogabe M, Nozaki H, Tanaka N, Kubota T, Kaji H, Kuno A, Togayachi A, Gotoh M, Nakanishi H, Nakanishi T, Mikami M, Suzuki N, Kiguchi K, Ikehara Y, Narimatsu H. Novel glycobiomarker for ovarian cancer that detects clear cell carcinoma J Proteome Res 2014 13(3):1624-35 PubMed ID: 24498956 DOI: 10.1021/pr401109n

5845 Konno-Shimizu M1, Yamamichi N, Inada K, Kageyama-Yahara N, Shiogama K, Takahashi Y, Asada-Hirayama I, Yamamichi-Nishina M, Nakayama C, Ono S, Kodashima S, Fujishiro M, Tsutsumi Y, Ichinose M, Koike K. Cathepsin E is a marker of gastric differentiation and signet-ring cell carcinoma of stomach: a novel suggestion on gastric tumorigenesis. PLoS One 2013 8(2):e56766 PubMed ID: 23451082 DOI: 10.1371/journal.pone.0056766

5847 Zhao L, Yasumoto K, Kawashima A, Nakagawa T, Takeuchi S, Yamada T, Matsumoto K, Yonekura K, Yoshie O, Yano S. Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer. Cancer Sci 2013 104(12):1640-6 PubMed ID: 24118504 DOI: 10.1111/cas.12301

6075 Murakami H, Nakanishi H, Tanaka H, Ito S, Misawa K, Ito Y, Ikehara Y, Kondo E, Kodera Y. Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potential. Gastric Cancer 2013 16(1):74-83 PubMed ID: 22450770 DOI: 10.1007/s10120-012-0149-2

13662 Murakami H, Ito S, Tanaka H, Kondo E, Kodera Y, Nakanishi H. Establishment of new intraperitoneal paclitaxel-resistant gastric cancer cell lines and comprehensive gene expression analysis Anticancer Res 2013 33(10):4299-307 PubMed ID: 24122996

5853 Nakanishi H, Ito S, Matsui M, Ito Y, Misawa K, Kodera Y. Noninvasive and real-time fluorescence imaging of peritoneal metastasis in nude mice. Methods Mol Biol 2012 872:85-95 PubMed ID: 22700405 DOI: 10.1007/978-1-61779-797-2_6

5856 Sato Y, Morimoto K, Kubo T, Yanagihara K, Seyama T. High mannose-binding antiviral lectin PFL from Pseudomonas fluorescens Pf0-1 promotes cell death of gastric cancer cell MKN28 via interaction with α2-integrin. PLoS One 2012 7(9):e45922 PubMed ID: 23029318 DOI: 10.1371/journal.pone.0045922

16307 Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Waraya M, Kawamata H, Nishimiya H, Nakamura K, Watanabe M. Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer BMC Cancer 2011 11:122 PubMed ID: 21466710 DOI: 10.1186/1471-2407-11-122

8118 Shirasawa Y, Shibahara-Sone H, Iino T, Ishikawa F. Bifidobacterium bifidum BF-1 suppresses Helicobacter pylori-induced genes in human epithelial cells. J. Dairy Sci. 2010 93:4526-34 PubMed ID: 20854986 DOI: 10.3168/jds.2010-3274

6410 Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y. Is parainfluenza virus a threatening virus for human cancer cell lines? Hum Cell 2009 22(3):81-4 PubMed ID: 19624309 DOI: 10.1111/j.1749-0774.2009.00071.x

5893 Hara M, Nakanishi H, Jun Q, Kanemitsu Y, Ito S, Mochizuki Y, Yamamura Y, Kodera Y, Tatematsu M, Hirai T, Kato T. Comparative analysis of intraperitoneal minimal free cancer cells between colorectal and gastric cancer patients using quantitative RT-PCR: possible reason for rare peritoneal recurrence in colorectal cancer. Clin Exp Metastasis 2007 24(3):179-89 PubMed ID: 17487561 DOI: 10.1007/s10585-007-9067-9

5899 Yokoyama H, Ikehara Y, Kodera Y, Ikehara S, Yatabe Y, Mochizuki Y, Koike M, Fujiwara M, Nakao A, Tatematsu M, Nakanishi H. Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis. Br J Cancer 2006 95(11):1504-13 PubMed ID: 17088902 DOI: 10.1038/sj.bjc.6603459

5906 Imura K, Ueda Y, Hayashi T, Itoh T, Shimizu K, Tamai H, Yano Y, Naito K, Kohara J, Nakane K, Matsuura Y, Takeda A, Takeda T, Kawai K, Yamagishi H. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique. Int J Oncol 2006 29(3):531-9

13874 Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique Imura K, Ueda Y, Hayashi T, Itoh T, Shimizu K, Tamai H, Yano Y, Naito K, Kohara J, Nakane K, Matsuura Y, Takeda A, Takeda T, Kawai K, Yamagishi H. Int J Oncol 2006 29(3):531-9 PubMed ID: 16865268

3077 Nakatsu N, Yoshida Y, Yamazaki K, Nakamura T, Dan S, Fukui Y, Yamori T Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays. Mol Cancer Ther 2005 4:399-412 PubMed ID: 15767549 DOI: 10.1158/1535-7163.MCT-04-0234

5910 Nakanishi H, Ito S, Mochizuki Y, Tatematsu M. Evaluation of chemosensitivity of micrometastases with green fluorescent protein gene-tagged tumor models in mice. Methods Mol Med 2005 2005;111:351-62 PubMed ID: 15911990 DOI: 10.1385/1-59259-889-7:351

2807 Shida D, Kitayama J, Yamaguchi H, Hama K, Aoki J, Arai H, Yamashita H, Mori K, Sako A, Konishi T, Watanabe T, Sakai T, Suzuki R, Ohta H, Takuwa Y, Nagawa H Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells. Exp Cell Res 2004 301:168-78 PubMed ID: 15530853 DOI: 10.1016/j.yexcr.2004.08.008

5397 Mochizuki Y, Nakanishi H, Kodera Y, Ito S, Yamamura Y, Kato T, Hibi K, Akiyama S, Nakao A, Tatematsu M. TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Clin Exp Metastasis 2004 21(1):39-47. PubMed ID: 15065601 DOI: 10.1023/b:clin.0000017181.01474.35

3796 Fukami T, Fukuhara H, Kuramochi M, Maruyama T, Isogai K, Sakamoto M, Takamoto S, Murakami Y. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines. Int J Cancer 2003 107(1):53-9 PubMed ID: 12925956 DOI: 10.1002/ijc.11348

5931 Terashima M, Fujiwara H, Takagane A, Abe K, Irinoda T, Nakaya T, Yonezawa H, Oyama K, Saito K, Kanzaki N, Ohtani S, Nemoto T, Hoshino Y, Kogure M, Gotoh M. Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer. Gastric Cancer 2003 6 Suppl 1:71-81. PubMed ID: 12775024 DOI: 10.1007/s10120-003-0221-z

5932 Fujiwara 1, Terashima M, Irinoda T, Takagane A, Abe K, Nakaya T, Yonezawa H, Oyama K, Takahashi M, Saito K, Takechi T, Fukushima M, Shirasaka T. Superior antitumour activity of S-1 in tumours with a high dihydropyrimidine dehydrogenase activity. Eur J Cancer 2003 39(16):2387-94 PubMed ID: 14556932 DOI: 10.1016/s0959-8049(03)00513-6

5935 Dan S, Shirakawa M, Mukai Y, Yoshida Y, Yamazaki K, Kawaguchi T, Matsuura M, Nakamura Y, Yamori T. Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines. Cancer Sci 2003 94(12):1074-82 PubMed ID: 14662023 DOI: 10.1111/j.1349-7006.2003.tb01403.x

5941 Fujiwara H, Terashima M, Irinoda T, Takagane A, Abe K, Kashiwaba M, Oyama K, Takahashi M, Maesawa C, Saito K, Takechi T, Fukushima M. Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR. Jpn J Cancer Res 2002 93(12):1342-50 PubMed ID: 12495474 DOI: 10.1111/j.1349-7006.2002.tb01243.x

3763 Takaishi S, Sawada M, Morita Y, Seno H, Fukuzawa H, Chiba T. Identification of a novel alternative splicing of human FGF receptor 4: soluble-form splice variant expressed in human gastrointestinal epithelial cells. Biochem Biophys Res Commun 2000 19;267(2):658-62 PubMed ID: 10631118 DOI: 10.1006/bbrc.1999.2010

1906 Iida S, Akiyama Y, Nakajima T, Ichikawa W, Nihei Z, Sugihara K, Yuasa Y. Alterations and hypermethylation of the p14(ARF) gene in gastric cancer Int J Cancer 2000 87(5):654-8 PubMed ID: 10925358 DOI: 10.1002/1097-0215(20000901)87:5<654::aid-ijc6>3.0.co;2-p

6386 Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim EH, Soma T, Tatekawa T, Kawakami M, Asada M, Kishimoto T, Sugiyama H. Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res 1999 90(2):194-204 PubMed ID: 10189890 DOI: 10.1111/j.1349-7006.1999.tb00733.x

17255 Saijo Y, Hong X, Tanaka M, Tazawa R, Liu SQ, Saijo K, Ohno T, Koike K, Ohkuda K, Satoh K, Nukiwa T. Autologous high-killing cytotoxic T lymphocytes against human lung cancer are induced using interleukin (IL)-1beta, IL-2, IL-4, and IL-6: possible involvement of dendritic cells Clin Cancer Res 1999 5(5):1203-9 PubMed ID: 10353758

6409 Hassan S, Kinoshita Y, Kawanami C, Kishi K, Matsushima Y, Ohashi A, Funasaka Y, Okada A, Maekawa T, He-Yao W, Chiba T. Expression of protooncogene c-kit and its ligand stem cell factor (SCF) in gastric carcinoma cell lines. Dig Dis Sci 1998 43(1):8-14 PubMed ID: 9508539 DOI: 10.1023/a:1018851415704

5973 Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines. Genes Chromosomes Cancer 1997 20(1):98-102 PubMed ID: 9290961

2062 Wang, D S, Ueno Y, Oyamada H, Kojima S Accumulation of NCC-CO-411 monoclonal antibody in human colorectal adenocarcinoma through binding of the released carcinoembryonic antigen in nude mice. Biol Pharm Bull 1996 19:915-21 PubMed ID: 8839961 DOI: 10.1248/bpb.19.915

2177 Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines Jpn J Cancer Res 1996 87:1153-1159 PubMed ID: 9045944 DOI: 10.1111/j.1349-7006.1996.tb03125.x

2063 Wang, D., S., Ueno, Y., Oyamada, H., and Kojima, S. Radioimmunoimaging of Human Colorectal Adenocarcinoma with a Monoclonal Antibody, NCC-CO-411, Against a Human Carcinoembryonic Antigen Antibody, Immunoconjugates, and Radiopharmaceuticals 1995 8:129-143

6407 Matsushima Y, Kinoshita Y, Nakata H, Inomoto-Naribayashi Y, Asahara M, Kawanami C, Nakamura A, Ito M, Matsui T, Fujiwara T, et al. Gastrin receptor gene expression in several human carcinomas. Jpn J Cancer Res 1994 85(8):819-24 PubMed ID: 7928627 DOI: 10.1111/j.1349-7006.1994.tb02953.x